JAK1 and B-cell chronic lymphocytic leukemia: These targets include genes known for these functions, such as STAT3 (LFC = 1; RS: 52.9% vs. CLL: 22.8%) and JAK1 (LFC = 0.32; RS: 70% vs. CLL: 44.9%).